These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 28840453)

  • 1. Immunotherapy in Gynecologic Cancers: Are We There Yet?
    Pakish JB; Jazaeri AA
    Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed.
    Levinson K; Dorigo O; Rubin K; Moore K
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e126-e140. PubMed ID: 31099679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-oncology for Gynecologic Malignancies.
    How J; Patel A; Jazaeri A
    Adv Exp Med Biol; 2020; 1244():149-182. PubMed ID: 32301014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.
    Jazaeri A; Coleman RL; Sood AK; Frumovitz MM; Soliman PT; Shafer A; Cutrera JJ; Klinger M; Sharafi SE; Johnson CAL; Villanueva VF; Hinchcliff EM; Dickens A; Cain KE; Anderson JE; Lu KH; Westin SN
    Gynecol Oncol; 2018 Nov; 151(2):374-380. PubMed ID: 30213435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies.
    Ring KL; Pakish J; Jazaeri AA
    Cancer J; 2016; 22(2):101-7. PubMed ID: 27111905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-Oncology for Gynecologic Malignancies.
    How JA; Patel A; Jazaeri AA
    Adv Exp Med Biol; 2021; 1342():193-232. PubMed ID: 34972966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.
    Maxwell R; Jackson CM; Lim M
    Curr Treat Options Oncol; 2017 Aug; 18(8):51. PubMed ID: 28785997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic Approaches to Biliary Cancer.
    Shah UA; Nandikolla AG; Rajdev L
    Curr Treat Options Oncol; 2017 Jul; 18(7):44. PubMed ID: 28660602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy: Checkpoint Inhibitors in Lynch-Associated Gynecologic Cancers.
    Ferriss JS; Williams-Brown MY
    Curr Treat Options Oncol; 2019 Aug; 20(10):75. PubMed ID: 31444655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.
    Menderes G; Hicks C; Black JD; Schwab CL; Santin AD
    Expert Opin Biol Ther; 2016 Aug; 16(8):989-1004. PubMed ID: 27070175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of cancer immunotherapy for gynecologic malignancies.
    Nishio H; Iwata T; Aoki D
    Jpn J Clin Oncol; 2021 Feb; 51(2):167-172. PubMed ID: 33244581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
    Mooradian MJ; Sullivan RJ
    Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in gynecological cancers: where are we?
    Polastro L; Closset C; Kerger J
    Curr Opin Oncol; 2020 Sep; 32(5):459-470. PubMed ID: 32675594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors: The linchpins of modern immunotherapy.
    Wilky BA
    Immunol Rev; 2019 Jul; 290(1):6-23. PubMed ID: 31355494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell target antigens across major gynecologic cancers.
    Rodriguez-Garcia A; Minutolo NG; Robinson JM; Powell DJ
    Gynecol Oncol; 2017 Jun; 145(3):426-435. PubMed ID: 28377094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma.
    Saeed A; Park R; Al-Jumayli M; Al-Rajabi R; Sun W
    Clin Colorectal Cancer; 2019 Jun; 18(2):81-90. PubMed ID: 30905548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Approaches for Immune Directed Treatment for Ovarian Cancer.
    Hardwick N; Frankel PH; Cristea M
    Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers.
    Castellano T; Moore KN; Holman LL
    Clin Ther; 2018 Mar; 40(3):372-388. PubMed ID: 29530456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
    Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
    J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.